Overview Financials News + Filings Key Docs Insiders
|
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Nov-29-14 | Dec-31-13 | Nov-29-13 | Dec-31-12 | Nov-29-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.3 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | -0.3 |
Selling, general and administrative [+] | 0.1 | 0.1 | 0.0 | 0.4 | 0.0 | 0.3 | 0.0 | 0.3 |
Sales and marketing | | | | 0.3 | | 0.3 | | 0.2 |
General and administrative [+] | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
General and administrative expenses | 0.1 | 0.1 | 0.0 | | 0.0 | | 0.0 | |
Professional fees | 0.0 | 0.0 | 0.1 | | 0.0 | | 0.0 | |
Other selling, general and administrative | | | | 0.3 | | 0.3 | | 0.2 |
Other operating expenses | | | 0.1 | | 0.0 | -0.3 | 0.0 | -0.3 |
EBIT [+] | -0.1 | -0.1 | -0.1 | -0.4 | -0.1 | -0.3 | -0.1 | -0.3 |
EBIT growth | -0.4% | -37.2% | 62.9% | 32.4% | -2.9% | 23.9% | 6.7% | 32.6% |
Non-recurring items | | | | 0.0 | | 0.0 | | 0.0 |
Other income (expense), net | | | | 0.0 | | 0.0 | | 0.0 |
Pre-tax income | -0.1 | -0.1 | -0.1 | -0.4 | -0.1 | -0.3 | -0.1 | -0.3 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.1 | -0.1 | -0.1 | -0.4 | -0.1 | -0.3 | -0.1 | -0.3 |
|
Basic EPS [+] | ($0.01) | ($0.01) | ($0.02) | | ($0.01) | | ($0.01) | |
Growth | -0.4% | -37.2% | 62.9% | | -2.9% | | 6.7% | |
Diluted EPS [+] | ($0.01) | ($0.01) | ($0.02) | | ($0.01) | | ($0.01) | |
Growth | -0.4% | -37.2% | 62.9% | | -2.9% | | 6.7% | |
|
Shares outstanding (basic) | 5.8 | 5.8 | 5.8 | | 5.8 | | 5.8 | |
Growth | 0.0% | 0.0% | 0.0% | | 0.0% | | 0.0% | |
Shares outstanding (diluted) | 5.8 | 5.8 | 5.8 | | 5.8 | | 5.8 | |
Growth | 0.0% | 0.0% | 0.0% | | 0.0% | | 0.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|